focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end four-day winning run as UK's FTSE drags

Thu, 13th Aug 2020 09:39

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* FTSE 100 leads declines on ex-dividend trading

* Cyclical sectors hand back some of this week's gains

* Thyssenkrupp slides on flagging losses in steel unit

* TUI sinks to 1 bln euro loss in Q3
(Updates to market close)

By Sruthi Shankar and Sagarika Jaisinghani

Aug 13 (Reuters) - European stocks broke a four-day winning
streak on Thursday as ex-dividend trading and a stronger pound
hit the UK's blue-chip companies, while investors sold off banks
and energy stocks that have outperformed this week.

The pan-European STOXX 600 closed 0.6% lower, with
London's FTSE 100 sliding 1.5% as a jump in the pound
hurt exporters on the index, while heavyweights like AstraZeneca
, BP, and GlaxoSmithKline traded without
entitlement to a dividend payout, hitting their shares.

Reversing a recent trend, investors favoured pockets of
markets that have remained resilient in the wake of the
coronavirus crisis such as the technology sector. On Wall
Street, Apple was set to record $2 trillion in market
capitalisation.

That left some of the cyclical sectors that are more exposed
to an economic downturn, such as banks, oil & gas
, miners and automakers, falling between
0.8% and 1.9%.

Geir Lode, head of global equities international at
Federated Hermes, noted that it is difficult to gauge whether a
rally in these cheaper stocks will be sustained.

"It reflects the uncertainty that still pervades the world
as we continue to negotiate our way back to normality as well as
increasing U.S.-China tensions," Lode wrote in a note.

After a U.S. move to ban two popular Chinese apps last week,
investors were nervous about upcoming talks between Beijing and
Washington officials over a trade deal agreed earlier this year.

Meanwhile, U.S. Democrats and Republicans remain deadlocked
after weeks of wrangling over a fifth coronavirus aid bill to
support a struggling economy.

Trillions of dollars in stimulus and a stellar rally in
technology stocks have helped the U.S. S&P 500 index
reach striking distance of a record high. The European blue-chip
index is still about 15% below its February peak, but
the pace of recovery for both from a market crash in March has
been similar.

Weak earnings also dented the mood, with struggling
conglomerate Thyssenkrupp plunging 16.3% after it said
its steel unit would rack up 1 billion euros ($1.2 billion) in
operating losses this year, raising pressure to fix or sell the
division.

TUI, the world's largest tourism company, fell 6.2%
as it sank to a 1.1 billion euro ($1.30 billion) loss in the
third quarter due to the COVID-19 pandemic.

Danish brewer Carlsberg slid 5.8% on a warning
that lockdowns will impact sales in the second half of the year
in its key markets of China and Western Europe.

(Reporting by Sruthi Shankar in Bengaluru; Additional reporting
by Sagarika Jaisinghani; Editing by Arun Koyyur, Bernard Orr and
Giles Elgood)

More News
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.